Matrix metalloproteinases can facilitate the heparanase-induced promotion of phenotypic change in vascular smooth muscle cells

Atherosclerosis

Volumn 145, Issue 1, 1999, Pages 97-106

  Fitzgerald, Melinda ^a   Hayward, Ian P ^a   Thomas, Anita C ^a   Campbell, Gordon R ^a   Campbell, Julie H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cell phenotype; Heparan sulphate proteoglycan; Heparanase; Metalloproteinase; Vascular smooth miscle

Indexed keywords

BATIMASTAT; COLLAGENASE; GELATINASE A; GELATINASE B; HEPARANASE; MATRIX METALLOPROTEINASE; PROTEOHEPARAN SULFATE; STROMELYSIN; BETA GLUCURONIDASE; DNA; DRUG DERIVATIVE; GLYCOSIDASE; METALLOPROTEINASE; PHENYLALANINE; THIOPHENE DERIVATIVE; THYMIDINE;

ANIMAL TISSUE; AORTA; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; ENZYME ASSAY; IMMUNOHISTOLOGY; MYOFILAMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RABBIT; SMOOTH MUSCLE FIBER; TISSUE INJURY; VASCULAR SMOOTH MUSCLE; ANIMAL; ARTERIOSCLEROSIS; BALLOON DILATATION; BIOSYNTHESIS; CAROTID ARTERY; CELL DIVISION; COCULTURE; DRUG ANTAGONISM; HUMAN; MACROPHAGE; METABOLISM; MICROFILAMENT; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; ARTERIOSCLEROSIS; BALLOON DILATATION; CAROTID ARTERIES; CELL DIVISION; COCULTURE TECHNIQUES; DNA; GLUCURONIDASE; GLYCOSIDE HYDROLASES; HUMANS; MACROPHAGES; METALLOENDOPEPTIDASES; MICROFILAMENTS; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; PHENYLALANINE; RABBITS; THIOPHENES; THYMIDINE;

EID: 0032586870     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00019-2     Document Type: Article

References (53)

1. Campbell J.H., Rennick R.E., Kalevitch S.G., Campbell G.R. Heparan sulphate degrading enzymes induce modulation of smooth muscle phenotype. Exp. Cell. Res. 200:1992;156-167.
2. Chamley-Campbell J.H., Campbell G.R., Ross R. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J. Cell. Biol. 8:1981;379-383.
3. Chamley-Campbell J.H., Campbell G.R. What controls smooth muscle phenotype? Atherosclerosis. 40:1981;347-357.
4. Campbell J.H., Kocher O., Skalli O., Gabbiani G., Campbell G.R. Cytodifferentiation and expression of α-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Arteriosclerosis. 9:1989;633-643.
5. Ang A.H., Tachas G., Campbell J.H., Bateman J.F., Campbell G.R. Collagen synthesis by cultured rabbit aortic smooth muscle cells. Biochem. J. 265:1990;461-469.
6. Campbell J.H., Reardon M.F., Campbell G.R., Nestel P.J. Metabolism of atherogenic lipoproteins by smooth muscle cells of different phenotype in culture. Arteriosclerosis. 5:1985;318-328.
7. Campbell G.R., Campbell J.H. The phenotypes of smooth muscle expressed in human atheroma. Annals. NY. Acad. Sci. 598:1990;143-158.
8. Gabbiani G., Kocher O., Bloom W.S., Vandekerckhove J., Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J. Clin. Invest. 73:1984;148-152.
9. Mosse P.R.L., Campbell G.R., Wang Z.L., Campbell J.H. Smooth muscle phenotypic expression in human carotid arteries I. Lab. Invest. 53:1985;556-562.
10. Mosse P.R.L., Campbell G.R., Campbell J.H. Smooth muscle phenotypic expression in human carotid arteries II. Arteriosclerosis. 6:1986;664-669.
11. Joris I., Zand T., Nunnari J.J., Krolikowski F.J., Majno G. Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am. J. Pathol. 113:1983;341-358.
12. Vlodavsky I., Eldor A., Haimovitz-Friedman A. et al. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis. 12:1992;112-127.
13. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodeling. Trends. Genet. 6:1990;121-125.
14. Bendeck M.P., Zempo N., Clowes A.W., Galardy R.E., Reidy M.A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 75:1994;539-545.
15. Zempo N., Kenagy R.D., Au Y.P.T. et al. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J. Vasc. Surg. 20:1994;209-217.
16. Southgate K.M., Fisher M., Banning A.P. et al. Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. Circ. Res. 79:1996;1177-1187.
17. Strauss B.H., Robinson R., Batchelor W.B. et al. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ. Res. 79:1996;541-550.
18. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:1995;2493-2503.
19. Brown D.L., Hibbs M.S., Kearney M., Loushin C., Isner J.M. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Circulation. 91:1995;2125-2131.
20. Nikkari S.T., O'Brien K.D., Ferguson M. et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 92:1995;1393-1398.
21. Li Z., Li L., Zielke H.R. et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am. J. Pathol. 148:1996;121-128.
22. Herron G.S., Unemori E., Wong M. et al. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Arterioscler. Thromb. 11:1991;1667-1677.
23. Newman K.M., Jean-Claude J., Li H. et al. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J. Vasc. Surg. 20:1994;814-820.
24. Newman K.M., Ogata Y., Malon A.M. et al. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler. Thromb. 14:1994;1315-1320.
25. Sakalihasan N., Delvenne P., Nusgens B.V., Limet R., Lapière C.M. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J. Vasc. Surg. 24:1996;127-133.
26. Freestone T., Turner R.J., Coady A. et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 15:1995;1145-1151.
27. Southgate K.M., Davies M., Booth R.F.G., Newby A.C. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem. J. 288:1992;93-99.
28. Newby A.C., Southgate K.M., Davies M. Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis. Basic. Res. Cardiol. 89(S1):1994;59-70.
29. Davies B., Brown P.D., East N., Crimmin M.J., Balkwill F.R. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53:1993;2087-2091.
30. Stuart AK, Habeshaw JA, Davidson EA. Phagocytes in vitro. In: Weir DM (ed). Handbook of Experimental Immunology. Edinburgh: Blackwell Scientific, 1978; Ch. 31.
31. Campbell J.H., Campbell G.R. Culture techniques and their application to studies of vascular smooth muscle. Clin. Sci. 85:1993;501-513.
32. Baumgartner H.R. Eine neue methode zur erzeugung von thromben durch gezielte uberdehnung der gefasswand. Z. Ges. Exp. Med. 137:1963;227-247.
33. Bartlett M.R., Underwood P.A., Parish C.R. Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase. Immunol. Cell. Biol. 73:1995;113-124.
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
35. Rekhter M.D., Gordon D. Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques. J. Vasc. Res. 31:1994;280-286.
36. Brown P.D. Matrix metalloproteinase inhibitors: a novel class of anticancer agents. Adv. Enzyme. Regul. 35:1995;293-301.
37. Zempo N., Koyama N., Kenagy R.D., Lea H.J., Clowes A.W. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler. Thromb. Vasc. Biol. 16:1996;28-33.
38. Zervos E.E., Norman J.G., Gower W.R., Franz M.G., Rosemurgy A.S. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo. J. Surg. Res. 69:1997;367-371.
39. Welgus H.G., Campbell E.J., Cury J.D. et al. Neutral metalloproteinases produced by human mononuclear phagocytes. J. Clin. Invest. 86:1990;1496-1502.
40. Galis Z.S., Muszynski M., Sukhova G.K. et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75:1994;181-189.
41. Kenagy R.D., Nikkari S.T., Welgus H.G., Clowes A.W. Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. J. Clin. Invest. 93:1994;1987-1993.
42. Guarda E., Katwa L.C., Campbell S.E. et al. Extracellular matrix collagen synthesis and degradation following coronary balloon angioplasty. J. Mol. Cell. Cardiol. 28:1996;699-706.
43. Pauly R.R., Passaniti A., Bilato C. et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ. Res. 75:1994;41-54.
44. More R.S., Rutty G., Underwood M.J., Brack M.J., Gershlick A.H. Assessment of myointimal cellular kinetics in a model of angioplasty by means of proliferating cell nuclear antigen expression. Am. Heart. J. 128:1994;681-686.
45. Strauss B.H., Chisholm R.J., Keeley F.W. et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ. Res. 75:1994;650-658.
46. Graham L.D., Underwood P.A. Comparison of the heparanase enzymes from mouse melanoma cells, mouse macrophages, and human platelets. Biochem. Mol. Biol. Int. 39:1996;563-571.
47. Nakajima M., Irimura T., Nicolson G.L. Heparanases and tumor metastasis. J. Cell. Biochem. 36:1988;157-167.
48. Graham L.D., Hayward I.P., Underwood P.A. Activation of platelet heparitinase by vascular cell lysates. Biochem. Mol. Biol. Int. 37:1995;231-237.
49. Tyagi S.C., Meyer L., Kumar S. et al. Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions. Can. J. Cardiol. 12:1996;353-362.
50. Saksela O., Rifkin D.B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell. Biol. 110:1990;767-775.
51. Brunner G., Preissner K.T. Pericellular enzymatic hydrolysis: implications for the regulation of cell proliferation in the vessel wall and the bone marrow. Blood. Coag. Fibrin. 5:1994;625-639.
52. Clowes A.W., Clowes M.M., Au Y.P.T., Reidy M.A., Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ. Res. 67:1990;61-67.
53. Shireman P.K., McCarthy W.J., Pearce W.H. et al. Elevations of tissue type plasminogen activator and differential expression of urokinase type plasminogen activator in diseased aorta. J. Vasc. Surg. 25:1997;157-164.